The pharmaceuticals company Glenmark Pharma Ltd introduce medicine for the time with the combination of Teneligliptin (20mg) and Dapagliflozin (5mg/10mg) for the treatment of adult patients with type two diabetes, especially the ones with comorbidities.
- SpaceX Launches 21 Starlink Satellites from Florida
- Govt Begins Tur Procurement, Commits to 100% Purchase of Tur, Urad & Masur
- Russia, US May Start Ukraine Peace Talks Today
- Govt Begins India’s First Exploration Licence Auction for Critical Minerals
- BEML Shares Soar 6% on Inking MoUs with Siemens and Dragflow SRL
‘Zita D’ which contains Teneligliptin (20mg) andDapagliflozin (5 mg/10 mg). This medicine can be consumed by the patient once a day daily as per prescription, which helps to improve glycemic control and prevent complications in adult patients with type two diabetes, especially the ones with comorbidities, as per the statement said.
